Early Molecular Response to Imatinib Mesylate Predicts Long-Term Outcomes in CML Patients in A Postgraduate Research Institute — A single center Study. Planet (Barisal) [Internet]. 2024 Feb. 10 [cited 2024 Oct. 26];7(01):255-66. Available from: https://bdjournals.org/index.php/planet/article/view/427